BRPI0820765A2 - Métodos para a produção de um peptídeo insulinotrópico e peptídeos - Google Patents

Métodos para a produção de um peptídeo insulinotrópico e peptídeos

Info

Publication number
BRPI0820765A2
BRPI0820765A2 BRPI0820765-8A BRPI0820765A BRPI0820765A2 BR PI0820765 A2 BRPI0820765 A2 BR PI0820765A2 BR PI0820765 A BRPI0820765 A BR PI0820765A BR PI0820765 A2 BRPI0820765 A2 BR PI0820765A2
Authority
BR
Brazil
Prior art keywords
peptides
producing
methods
insulinotropic peptide
insulinotropic
Prior art date
Application number
BRPI0820765-8A
Other languages
English (en)
Inventor
Lin Chen
Yeun-Kwei Han
Christopher R Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0820765A2 publication Critical patent/BRPI0820765A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0820765-8A 2007-12-11 2008-12-02 Métodos para a produção de um peptídeo insulinotrópico e peptídeos BRPI0820765A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US723807P 2007-12-11 2007-12-11
PCT/EP2008/066585 WO2009074483A2 (en) 2007-12-11 2008-12-02 Insulinotropic peptide synthesis using solid and solution phase combination techniques

Publications (1)

Publication Number Publication Date
BRPI0820765A2 true BRPI0820765A2 (pt) 2015-06-16

Family

ID=40755926

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820765-8A BRPI0820765A2 (pt) 2007-12-11 2008-12-02 Métodos para a produção de um peptídeo insulinotrópico e peptídeos

Country Status (17)

Country Link
US (1) US8227571B2 (pt)
EP (1) EP2222695A2 (pt)
JP (1) JP2011506376A (pt)
KR (1) KR20100102652A (pt)
CN (1) CN101903400B (pt)
AR (1) AR069608A1 (pt)
AU (1) AU2008334783A1 (pt)
BR (1) BRPI0820765A2 (pt)
CA (1) CA2707132A1 (pt)
CL (1) CL2008003660A1 (pt)
IL (1) IL205932A0 (pt)
MX (1) MX2010006044A (pt)
PE (1) PE20091214A1 (pt)
RU (1) RU2010128247A (pt)
TW (1) TWI374890B (pt)
WO (1) WO2009074483A2 (pt)
ZA (1) ZA201003849B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2344519T3 (en) * 2008-11-07 2017-01-23 Massachusetts Gen Hospital C-TERMINAL FRAGMENTS OF GLUCAGON SIMILAR PEPTID-1 (GLP-1)
EP2424888A2 (en) * 2009-05-01 2012-03-07 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
EP3412680B1 (en) 2011-04-05 2020-11-04 Curara AB Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment
EP2729157B1 (en) 2011-07-06 2019-01-16 The General Hospital Corporation A pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) for use in treatment
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
EP2948468A1 (en) 2013-01-28 2015-12-02 Solae, LLC Novel polypeptides having satiety hormone releasing activity
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
EP3692056A1 (en) * 2017-10-04 2020-08-12 Chemical & Biopharmaceutical Laboratories of Patras S.A. A process for preparing a glucagon-like peptide
KR20200001546A (ko) * 2018-06-27 2020-01-06 주식회사 시선바이오머티리얼스 Pna 올리고머의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324348C (en) * 1998-03-23 2006-03-14 Trimeris, Inc. Methods and compositions for peptide synthesis
CZ295890B6 (cs) * 1998-12-07 2005-11-16 Societe De Conseils De Recherches Et D'application Analogy GLP-1, mající kyselinu aminoizomáselnou pozici 8 a D-arginin na pozici 36, jejich použití a farmaceutické prostředky je obsahující
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
CN1918177A (zh) * 2003-12-18 2007-02-21 诺和诺德公司 新型glp-1化合物
WO2005066207A1 (en) * 2004-01-08 2005-07-21 Theratechnologies Inc. Glucagon-like peptide-1 analogs with long duration of action
MX2007007917A (es) * 2004-12-30 2007-08-14 Hoffmann La Roche Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios.
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments
KR20070111463A (ko) * 2004-12-30 2007-11-21 에프. 호프만-라 로슈 아게 펩타이드 중간체 단편 ⅲ을 사용하는 합성 방법
EP1891106A2 (en) * 2005-05-05 2008-02-27 Cadila Healthcare Ltd. Novel compounds as glp-i agonists
KR101297942B1 (ko) * 2006-02-08 2013-08-19 론자 아게 글루카곤형 펩티드의 합성
PT2035451E (pt) * 2006-06-23 2010-06-09 Hoffmann La Roche Síntese de péptidos insulinotrópicos
EP2205624B1 (en) * 2007-10-27 2016-09-07 Corden Pharma Colorado, Inc. Insulinotropic peptide synthesis using solid and solution phase combination techniques

Also Published As

Publication number Publication date
US20090292108A1 (en) 2009-11-26
CN101903400B (zh) 2013-12-18
ZA201003849B (en) 2011-04-28
AU2008334783A1 (en) 2009-06-18
JP2011506376A (ja) 2011-03-03
WO2009074483A2 (en) 2009-06-18
EP2222695A2 (en) 2010-09-01
CN101903400A (zh) 2010-12-01
US8227571B2 (en) 2012-07-24
WO2009074483A3 (en) 2010-05-14
IL205932A0 (en) 2010-11-30
MX2010006044A (es) 2010-06-23
TWI374890B (en) 2012-10-21
AR069608A1 (es) 2010-02-03
KR20100102652A (ko) 2010-09-24
PE20091214A1 (es) 2009-08-14
CA2707132A1 (en) 2009-06-18
RU2010128247A (ru) 2012-01-20
CL2008003660A1 (es) 2010-01-04
TW200927756A (en) 2009-07-01

Similar Documents

Publication Publication Date Title
BRPI0820765A2 (pt) Métodos para a produção de um peptídeo insulinotrópico e peptídeos
IL193695A0 (en) Antibodies against amyloid-beta peptide
NO20082895L (no) Hoytrykks-hoyspenningspenetratorsammensetning
IL200478A (en) Kif20a-derived peptide compounds
ZA200905945B (en) Amino Phosphine
BRPI0813858A2 (pt) Método para produzir peptídeo
DK2171053T3 (da) Natriuretiske polypeptider
ATE522545T1 (de) Amidiertes insulin glargin
BRPI0915367A2 (pt) peptídeos e epítopos anti-p2x7
EP2017283A4 (en) Peptides
BRPI0917564A2 (pt) bioensaio para proteína poli-q
BRPI0814763A2 (pt) Peptídeos imunomoduladores
BRPI0922772A2 (pt) métodos para selecionar polipeptídeos resistentes a protease
GB0723712D0 (en) Peptides
GB0821687D0 (en) Peptides
EP2101804A4 (en) PRO-ANGIOGENIC PEPTIDES
BRPI0917206A2 (pt) Tablete de liberação prolongada e método para a fabricação e utilização do mesmo
IL206013A0 (en) Stat3 epitope peptides
GB0725201D0 (en) Peptide fusion proteins
GB0618748D0 (en) Peptide
GB0703945D0 (en) Peptide
EP2188305A4 (en) MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS
GB0605774D0 (en) Peptide
DK2081952T3 (da) Peptider
BRPI1011474A2 (pt) peptideos antagonisticos para frizzled-1 e frizzled-2

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.